{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:10:44Z","timestamp":1786990244845,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":197,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.idcr.2024.e02035","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T19:32:14Z","timestamp":1721503934000},"page":"e02035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A higher area under the concentration-time curve\/minimum inhibitory concentration target as a potential prognostic factor for vancomycin treatment of methicillin-resistant Staphylococcus aureus meningitis: A case report"],"prefix":"10.1016","volume":"37","author":[{"given":"Kenichi","family":"Nakazono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruaki","family":"Wakatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Katsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kunishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2024.e02035_bib1","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious Diseases Society of America\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2024.e02035_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/pharmaceutics14030489","article-title":"Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese society of chemotherapy and the Japanese society of therapeutic drug monitoring","volume":"14","author":"Matsumoto","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.idcr.2024.e02035_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"A revised consensus guideline and review by the American Society of Health System Pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"Suppl. 4","key":"10.1016\/j.idcr.2024.e02035_bib4","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1093\/cid\/ciaa1536","article-title":"Evidence-based guideline for therapeutic drug monitoring of vancomycin: 2020 update by the division of therapeutic drug monitoring, Chinese pharmacological society","volume":"71","author":"He","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2024.e02035_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11095-021-03030-y","article-title":"Performance of area under the concentration-time curve estimations of vancomycin with limited sampling by a newly developed web application","volume":"38","author":"Oda","year":"2021","journal-title":"Pharmaceut Res"},{"key":"10.1016\/j.idcr.2024.e02035_bib6","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.idcr.2024.e02035_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/FTD.0000000000000359","article-title":"Is trough concentration of vancomycin predictive of the area under the curve? A clinical study in elderly patients","volume":"39","author":"Bel Kamel","year":"2017","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.idcr.2024.e02035_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/FTD.0000000000000622","article-title":"Examining the relationship between vancomycin area under the concentration time curve and serum trough levels in adults with presumed or documented Staphylococcal infections","volume":"41","author":"Clark","year":"2019","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.idcr.2024.e02035_bib9","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/AAC.03970-14","article-title":"Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis","volume":"59","author":"Casapao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2024.e02035_bib10","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/cid\/ciz051","article-title":"Vancomycin area under the curve and acute kidney injury: a meta-analysis","volume":"69","author":"Aljefri","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2024.e02035_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12879-021-05858-6","article-title":"The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing","volume":"21","author":"Tsutsuura","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idcr.2024.e02035_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jiac.2022.03.019","article-title":"Comparison of single trough-based area under the concentration\u2013time curve versus trough concentration for the incidence of vancomycin-associated nephrotoxicity","volume":"28","author":"Niwa","year":"2022","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.idcr.2024.e02035_bib13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/phar.2722","article-title":"Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: systematic review and meta-analysis","volume":"42","author":"Abdelmessih","year":"2022","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.idcr.2024.e02035_bib14","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1128\/AAC.44.5.1356-1358.2000","article-title":"Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit","volume":"44","author":"Alban\u00e8se","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idcr.2024.e02035_bib15","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1093\/jac\/dkv074","article-title":"Vancomycin serum concentrations do not adequately predict tissue exposure in diabetic patients with mild to moderate limb infections","volume":"70","author":"Hamada","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idcr.2024.e02035_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/jac\/dky543","article-title":"CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational study","volume":"74","author":"Blassmann","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idcr.2024.e02035_bib17","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1111\/bcp.14657","article-title":"Population pharmacokinetics of vancomycin in patients with ex ternal ventricular drain-associated ventriculitis","volume":"87","author":"Jalusic","year":"2021","journal-title":"Br J Clin Pharm"},{"key":"10.1016\/j.idcr.2024.e02035_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00241-23","article-title":"Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in patients with external ventricular drain","volume":"67","author":"Chen","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2024.e02035_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.893089","article-title":"The CSF vancomycin concentration in patients with post-operative intracranial infection can be predicted by the WBCs to total cells ratio and the serum trough concentration","volume":"13","author":"Fan","year":"2022","journal-title":"Front Neurol"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250924001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250924001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:15:56Z","timestamp":1741065356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250924001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":19,"alternative-id":["S2214250924001112"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2024.e02035","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A higher area under the concentration-time curve\/minimum inhibitory concentration target as a potential prognostic factor for vancomycin treatment of methicillin-resistant Staphylococcus aureus meningitis: A case report","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2024.e02035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02035"}}